“My appreciation goes to the South Florida Business Journal, Aetna and the other generous sponsors for this wonderful program that recognizes the significant efforts of those who provide health care services to our communities," said Dean Goldschmidt. "I believe that all of our area’s health care providers, together with our business community, can make South Florida a destination of choice for excellent health care."

Michael L. Friedland, M.D., executive regional dean of the UM Miller School of Medicine at Florida Atlantic University, won the excellence award in the category of Heath Care Education. A. Frederick Schild, M.D., professor of surgery at the Miller School, was included in an elite group of seven nominees for Physician of the Year.

 "The Debbie Institute has long been one of the treasured jewels of the Mailman Center for Child Development at the University of Miami Miller School of Medicine, and our partnerships with The Children’s Trust and United Way of Miami-Dade ensure that the Debbie Institute is a South Florida jewel as well," said Daniel Armstrong, Ph.D., professor and associate chairman of the Mailman Center for Child Development. "And Reach Out and Read is the model program to promote literacy for all children."

The Debbie Institute was recognized for providing exemplary services to children with developmental, genetic and neurological disabilities. Established more than 30 years ago, the Institute provides educational services for young children with disabilities, conducts research on the problems that impact children with disabilities and provides training for university students. The Institute also offers a multitude of services for children of all backgrounds including physical therapy and an auditory/oral education program.

Reach Out and Read, operated by the Miami-Dade Family Learning Partnership, is a nonprofit that currently fills 33 Miami-Dade County waiting rooms with books, promoting early literacy among underprivileged children as a routine part of pediatric primary care. Dr. Sanders, who was one of the first researchers to study the efficacy of Reach Out and Read, calls the program "one of the most evidence-based programs in preventive-care pediatrics."

“The partnerships that these programs have developed in the community provide hope for parents and children from all walks of life, and assure that the abilities of all children in our community are nourished and will flourish," said Dr. Armstrong.

The lecture will be held at noon tomorrow in the Lois Pope LIFE Center, seventh-floor auditorium. For more information, call 305-243-7108 or visit www.miamiproject.med.miami.edu/x381.xml.

At the end of the workshop, participants will be able to identify stressors during the holiday season, discuss situations where negative emotions might occur, describe strategies to avoid or minimize stress of intimate interactions, and identify one strategy that can be used to reduce or relieve holiday stress.

The lecture will be held at the Clinical Research Building, Medical Wellness Center tomorrow from 12:15 to 1:15 p.m.

To register, contact the Medical Wellness Center at 305- 243-7600.

Registration is required through Ulearn at http://ulearn.miami.edu/. For questions, please contact Sofia Aymerich at saymerich@med.miami.edu.

The lecture will be held this Thursday at noon in the Rosenstiel Medical Science Building, room 3109.

A light lunch will be served.

This activity is eligible for one continuing medical education credit and one continuing education unit. For more information, please contact Marie Corrales at 305-243-2576.

To register, visit http://ulearn.miami.edu. For help with registration, call the Professional Development and Training Office at 305-243-3090.

Diabetes is a condition in which the body does not produce or properly use insulin, the hormone that regulates blood sugar. It can affect many parts of the body and lead to serious complications if not well controlled.

For American Diabetes Month, UMatter Wellness Programs is offering a lunch-and-learn session, presented by Bresta Miranda-Palma, M.D., assistant professor of medicine, this Thursday from 12:15 to 1:15 p.m in Dominion Parking Garage, Professional Development and Training Office, suite 155. Please attend this session to learn about diabetes and what preventive steps you can take.

Space is limited. Please RSVP to Elizabeth Schy at 305-626-5723 or eschy@humana.com.

For more information, please contact Carmen Bou-Crick at 305-355-9073 or cbou@med.miami.edu.

The lecture will be held on Tuesday, Nov. 27, from noon to 1 p.m. in the Mailman Center for Child Development, room 3023. Please register at http://Ulearn.miami.edu. If you have any questions, please contact Sofia Aymerich at saymerich@med.miami.edu.

Sessions will take place in the Human Resources Benefits Office, suite D from 8:30 a.m. to 5 p.m.

To register for the session, visit http://ulearn.miami.edu. For more information, contact Fredricka Williams at 305-243-3090.

Lunch will be provided. No RSVP is required.

Dialogues in Research Ethics is a monthly conference series. For more information, please contact the UM Ethics Program at 305-243-5723 or ethics@miami.edu.

This class is free; reservations are required by calling 1-800-545-2292. A light lunch will be provided. 

• Smoking Cessation in  Women
Noella Dietz, Ph.D., is recruiting heterosexual women, current smokers, ages 18 to 45 in an established relationship, to participate in focus groups with the aim to better understand the relationship between feelings and behaviors, and how they affect smoking cessation attempts among women. Volunteers will receive $25 for being part of a one-hour meeting. For more information, please call 305-243-1120.

The Islet Cell Transplant Center at the Diabetes Research Institute is recruiting subjects with type 1 diabetes mellitus to participate in research studies that involve transplantation of islets, the insulin producing cells of the pancreas. For more information and eligibility criteria, call the department at 305-243-5321 or view the clinical trials section of the Web site www.diabetesresearch.org.

The University of Miami Cosmetic Center is recruiting for studies on photoaging, fine lines, wrinkles, crow's feet, sun damage, brown spots, uneven pigmentation, acne, keloids, scars and loose skin on the abdomen or upper arms. If you are interested in any of these studies, please call our research team at 305-531-5788 or visit the Web site at www.derm.net. Studies will take place at the University of Miami Cosmetic Center located in the Miami Heart Institute, 4701 N. Meridian Avenue, Nichol Building, Suite 7450, Miami Beach.

Carlos Hernandez-Cassis, M.D., from the Diabetes Research Institute, is currently recruiting patients 18 years of age and older with type II diabetes mellitus for participation in a research study to evaluate the safety and effectiveness of inhaled insulin. Patients must be taking multiple oral medication daily for more than 2 months and be non-smokers. Those who are interested should contact George Mejia-Galvis at 305-243-6573 or Gmejia2@med.miami.edu.

The Department of Psychology and the UM/SCCC Division of Biobehavioral Oncology and Cancer Epidemiology are conducting an NCI-funded quality of life research study with patients recently diagnosed with prostate cancer. Participants are eligible if they have been diagnosed with prostate cancer within 3 months and have not begun treatment. All participants will be followed for two years and will undergo psychosocial and medical assessments. Participants will be reimbursed up to $250 for their time and effort. If you or someone you know may be interested in more information about this study, please contact Natalie Escobio at 305-243-3329 or nescobio@med.miami.edu.  

Pulmonary and Critical Care Medicine is seeking patients with COPD for phase III protocol that will determine whether a once-a-day dose of an investigational medication, bronchodilator, will effectively improve breathing for 24 hours. You will be paid for your time and effort. For more information, please call 305-243-2568 or e-mail Eliana Mendes at emendes@med.miami.edu.

Robert M. Jackson, M.D., from the Division of Pulmonary and Critical Care Medicine, is seeking idiopathic pulmonary fibrosis (IPF) patients for an ongoing phase II clinical trial of vasodilator therapy (sildenafil). The objectives will be to assess possible therapeutic benefits of a vasodilator, sildenafil, on exercise tolerance and dyspnea in IPF patients and to observe changes in post-exercise markers of oxidant stress. The investigators seek patients with mild to moderate IPF and who have been diagnosed clinically. The study is open to at least ten additional patients. For more information, please contact Robert M. Jackson, M.D. or IPF program coordinator Carol Ramos at 305-575-3548 or by e-mail at rjackson2@med.miami.edu. This trial is funded by the Veterans Administration Research Service and is open to non-veterans of both genders. More information can be found at http://clinicaltrials.gov/ct/show/NCT00359736?order=2.

The Department of Psychology and the Division of Biobehavioral Oncology, Prevention, Epidemiology and Control at the Sylvester Comprehensive Cancer Center are conducting an NIH-funded intervention study to examine the effects of stress management on health and quality of life in women recently diagnosed with breast cancer (stages 0-III). Participants must have recently had surgery for breast cancer, have not yet begun chemotherapy or radiation treatment, and have fluency in English. Eligible women will participate in weekly group sessions over a period of five weeks and be compensated for completing three assessments (questionnaire packet, saliva collection, and blood draw). If you are interested in participating or would like further information about this study, please contact the study coordinator, Janny Rodriguez, at 305-284-2220 or jannyr@miami.edu.

Jay Skyler, M.D., and Jennifer Marks, M.D., from the Diabetes Research Institute, are currently recruiting patients 18 years of age and older with type 1 diabetes mellitus for participation in research studies to evaluate the safety and effectiveness of inhaled insulin. Patients must be taking multiple insulin injections daily, be non-smokers and in good health. Those who are interested should contact Rogelio Suarez at 305-243-6573 or rsuarez2@med.miami.edu.

Jennifer B. Marks, M.D., is currently recruiting patients ages 18 through 40 with type 1 diabetes mellitus with a recent diagnosis for participation in a research study to test the safety and effectiveness of an investigational medication. Patients must be taking multiple insulin injections daily and in good health. Those who are interested should contact Rogelio Suarez at 305-243-6573 or rsuarez2@med.miami.edu.

 Robert Kirsner, M.D., Ph.D., vice chairman of the Department of Dermatology and Cutaneous Surgery, is looking for people with foot ulcers as a complication of diabetes or venous insufficiency. Please contact Carol Kittles at 305-243-8485 for additional information on these studies.

The Department of Psychiatry and Behavioral Sciences is conducting a federally funded HIV behavioral intervention research study for women and their partners, the New Opportunities for Women 2 (NOW 2) Project. The project will address topics related to safer sex, sexual risk reduction, STDs and communication skills. The NOW 2 Project is currently recruiting English-speaking couples, in which one or both individuals must be HIV positive. Participants must be 18 years or older, willing to be tested for STDs, and answer personal questions in a confidential interview. Women and men who participate may each receive compensation of up to $360 for an entire year of participation (this includes attendance at all interviews, examinations and sessions). If interested, please contact Arnetta Phillips or Jackie Gomez, at 305-243-2103, or (aphillips@yahoo.com / jgomez4@med.miami.edu).

Do you or someone you know experience pain related to spinal cord injury? Eva Widerström-Noga, Ph.D., and her colleagues are conducting research into the nature and treatment of pain associated with spinal cord injury. Studies are enrolling now.  Eligible participants will be 18 to 70 years of age and at least two years post-injury.  If you are interested in enrolling, please call The Miami Project to Cure Paralysis at 305-243-8132 for information.

The Department of Psychology is recruiting participants for the following studies:

• A schizophrenia family study 
Have you or one of your relatives been diagnosed with schizophrenia or schizoaffective disorder? Are you in regular contact with this person? If so, you and your family may be eligible to participate in a free family-focused treatment research study. During the treatment, clinicians will provide factual information about schizophrenia and schizoaffective disorder. In addition, techniques to assist the family in coping with mental illness will be presented. Treatment is available in English and Spanish. If interested, please contact the Schizophrenia Family Project at 305-284-5455.

• A family factors and autism study
The aim of this project is to better understand families’ emotional reactions to autism spectrum disorders. We seek the participation of adults with high-functioning autism or Asperger’s and one of his or her parents. Participation will involve one hour-long telephone call. If you would like to help with this study or if you have any questions, please contact Stephanie Wasserman at 305-284-2307.

Researchers at the MRI Center need healthy subjects for a magnetic resonance imaging study. For more information, please visit http://midas.med.miami.edu/Research/MRStudies.htm.

The Department of Psychology and the Division of Cancer Prevention and Control is conducting a quality of life research intervention with advanced prostate cancer patients. Participants should have Stage III or IV prostate cancer and have recently or currently been treated with hormone therapy. Eligible participants will take part in a ten-week cognitive behavioral stress and affect management program or a health promotions program. Three psychosocial/medical assessments are also required. If you are interested in this study or would like more information, please contact Frank Penedo, Ph.D., at 305-243-3329, or fpenedo@miami.edu.

Daniel Santisteban, Ph.D., of the Center for Family Studies in the Department of Psychiatry and Behavioral Sciences, is currently conducting a research program that would provide adolescents and/or their family treatment for free. Participants must be 14 to 17 years old, have a parent or legal guardian willing to participate, meet DSM criteria for both substance abuse disorder and borderline personality disorder, and be willing to participate in four separate, paid evaluations. If interested, please contact Maite Mena, Psy.D., at 305-243-3658, or mmena@med.miami.edu for details. 

The Center for Research and Education on Aging and Technology Enhancement is conducting research with family caregivers of dementia patients who speak English and are 50 years of age or older. If you are not a caregiver but are interested in participating, you may be able to help as well. Participants will receive basic training on how to use the Internet and will be asked to look for information about care-giving and dementia. If you are interested in being a part of this research study, please call 305-355-9200. You will be paid for your time and effort.

The AIDS Clinical Research Unit, directed by Margaret Fischl, M.D., is recruiting participants for the following studies:

• An investigational polyclonal caprine IgG, HRG214, for HIV patients not responding to antiretroviral therapy. HRG214 contains antibodies that targets HIV infected CD4 cells and specific regions on HIV. Laboratory/animal studies suggest these antibodies are capable of killing or disabling HIV and preventing further infection.  Participants must have HIV RNA < 5000 copies/ml and CD4 cells < 200 cells/cmm. The study will evaluate 3 increasing dose of HRG214 in part I and compare HRG214 to optimized antiretroviral therapy in part II. HFG214 is given IV over about 30 minutes three times a week for up to 26 weeks. $100 provided each completed week of HRG214 treatment and $25 each completed week of observation

 • A phase II study of investigation use of recombination human keratinocyte growth factor (rHuKGF, palifermin) for patients with incomplete immune recovery on HAART.  rHuKGF may enhance thymus production of lymphocytes and increase CD4 cell counts. Participants must be 18 years and older, receiving antiretroviral therapy for at least 6 months with HIV RNA <200 and CD4 cell count <200 cells.  The study will evaluate 3 doses (20, 40 60 mcg/kg) of rHuKGF compared to placebo.  rHuKGF given IV bolus daily for 3 days. Follow up study visits at weeks 1,2,4,8, 12 and 24 with thymus CT scans at entry and week 12.

 • A phase II of an investigational glycosylated recombinant human IL-7 (CYT017, a cytokine that aids T-cell development and improves T-cell survival). Participants must be 18 years of age, receiving HAART for at least 12 months and have an HIV-1 RNA level < 1,000 copies/ml and CD4 cell count of 101– 400 cells/ccm. The study will evaluate three increasing doses (10, 20, 30 Fg/kg) of IL-7 given by SQ injection once a week for 3 weeks. Up to $275 in food certificates provided.

For more information on studies conducted by the AIDS Clinical Research Unit, contact Juan at 305-243-3838 or Leslie at L.Thompson@miami.edu.

Bruce Rubin, M.D., is currently performing a study on trigeminal neuralgia (TN) treatment with subcutaneous injections of BOTOX® to evaluate the effectiveness of treating facial pain associated with TN. Patients must have a diagnosis of TN for more than three months and be at least 18 years of age.
 
Dr. Rubin is also seeking patients for a research study on the treatment of tightness/spasticity in the wrist, fingers, and elbow caused by a stroke while evaluating the effect of BOTOX® on pulmonary functioning. Patients must be 18 years of age, have had a stroke six months ago or longer, have a pulmonary/breathing problem and cannot have used BOTOX® or any other botulinum toxin previously for any condition. Please contact Amy L. Kaye, ARNP, at 305-243-6223 for additional information on either of these studies.